Antiviral Activity of Vacuolar ATPase Blocker Diphyllin against SARS-CoV-2

Antiviral Activity of Vacuolar ATPase Blocker Diphyllin against SARS-CoV-2

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a causative agent of the pandemic coronavirus disease 2019 (COVID-19), which has resulted in over two million deaths worldwide to date. Diphyllin and diphyllinosides are known as natural blockers of cellular vacuolar ATPases, and so can...

Full description

Bibliographic Details
Main Authors: Michal Stefanik, Petra Strakova, Jan Haviernik, Andrew D. Miller, Daniel Ruzek, Ludek Eyer
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Microorganisms
Subjects:
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
vacuolar ATPase blocker
diphyllin
cleistanthin B
helioxanthin
antiviral activity
Online Access:https://www.mdpi.com/2076-2607/9/3/471

Internet

https://www.mdpi.com/2076-2607/9/3/471

Similar Items